Advertisement

Novel Properties and Biology of Scrapie Prions

  • S. B. Prusiner
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 172)

Abstract

Over the past 40 years, an impressive array of data has been accumulated indicating that many features of scrapie, kuru, Creutzfeldt-Jakob disease (CJD), and Gerstmann-Sträussler syndrome (GSS) are not typical of infectious diseases. Furthermore, the past two decades have witnessed the collection of numerous experimental results which argue strongly that the scrapie agent is a novel pathogen. To distinguish the scrapie and CJD agents from viroids and viruses, the term “prion” was introduced (Prusiner 1982). Although scrapie can be transmitted to animals by inoculation with extracts of diseased tissue, whether infection features in the spread of natural scrapie is unclear (Parry 1962, 1983; M’Gowan 1914; Westaway et al. 1989; Hourrigan et al. 1979; Gordon 1966; Dickinson et al. 1965; Dickinson 1976). Some investigators have proposed that natural scrapie is a genetic disease and that its transmissibility is incidental (Parry 1962, 1983) while others have argued vehemently that natural scrapie is an infectious disease (Dickinson et al. 1965; Dickinson 1976).

Keywords

Prion Protein Prion Disease Bovine Spongiform Encephalopathy Scrapie Agent Scrapie Prion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams DH (1970) The nature of the scrapie agent: a recent progress. Pathol Biol 18: 559–577PubMedGoogle Scholar
  2. Adams DH, Field EJ (1968) The infective process in scrapie. Lancet ii: 714–716Google Scholar
  3. Alper T (1985) Scrapie agent unlike viruses in size and susceptibility to inactivation by ionizing or ultraviolet radiation. Nature 317: 750PubMedGoogle Scholar
  4. Alper T, Haig DA, Clarke MC (1966) The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22: 278–284PubMedGoogle Scholar
  5. Alper T, Cramp WA, Haig DA, Clarke MC (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214: 764–766PubMedGoogle Scholar
  6. Alpers M (1987) Epidemiology and clinical aspects of kuru. In: Prusiner SB, McKinley MP (eds) Prions-novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Academic, Orlando, PP 451–465Google Scholar
  7. Bahmanyar S, Williams ES, Johnson FB, Young S, Gajdusek DC (1985) Amyloid plaques in spongiform encephalopathy of mule deer. J Comp Pathol 95: 1–5PubMedGoogle Scholar
  8. Baker HF, Ridley RM, Crowe TJ (1985) Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome? Br Med J 291:299–302Google Scholar
  9. Barker D, Schafer M, White R (1984) Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. 36: 131–138Google Scholar
  10. Barry RA, Prusiner SB (1986) Monoclonal antibodies to the cellular and scrapie prion proteins. J Infect Dis 154: 518–521PubMedGoogle Scholar
  11. Barry RA, Prusiner SB (1987) Immunology of prions. In: Prusiner SB, McKinley MP (eds) Prions-novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Academic, Orlando, pp 239–275Google Scholar
  12. Barry RA, McKinley MP, Bendheim PE, Lewis GK, DeArmond SJ, Prusiner SB (1985) Antibodies to the scrapie protein decorate prion rods. J Immunol 1 135: 603–613Google Scholar
  13. Basier K, Oesch B, Scott M, Westaway D, Wälchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417–428Google Scholar
  14. Bazan JF, Fletterick RJ, McKinley MP, Prusiner SB (1987) Predicted secondary structure and membrane topology of the scrapie prion. Protein Engineering 1: 125–135PubMedGoogle Scholar
  15. Beck E, Daniel PM, Parry HB (1964) Degeneration of the cerebellar and hypothalamo-neurohypophysial systems in sheep with scrapie and its relationship to human system degenerations. Brain 87: 153–176PubMedGoogle Scholar
  16. Bellinger-Kawahara C, Cleaver JE, Diener TO, Prusiner SB (1987) Purified scrapie prions resist inactivation by UV irradiation. J Virol 61: 159–166PubMedGoogle Scholar
  17. Bellinger-Kawahara CG, Kempner E, Groth D, Gabizon R, Prusiner SB (1988) Scrapie prion liposomes and rods ehibit target sizes of 55,000 Da. Virology 164: 537–541PubMedGoogle Scholar
  18. Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB (1984) Antibodies to a scrapie prion protein. Nature 310: 418–421PubMedGoogle Scholar
  19. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209–213PubMedGoogle Scholar
  20. Bookman JM, Kingsbury DT, McKinley MP, Bendheim PE, Prusiner SB (1985) Creutzfeldt-Jakob disease proteins in human brains. N Engl J Med 312: 73–78Google Scholar
  21. Bockman JM, Prusiner SB, Tateishi J, Kingsbury DT (1987) Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes. Ann Neurol 21: 589–595PubMedGoogle Scholar
  22. Bolton DC, Bendheim PE, Marmorstein AD, Potempska A (1987) Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys 258: 579–590PubMedGoogle Scholar
  23. Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218: 1309–1311PubMedGoogle Scholar
  24. Boltion DC, Mckinley MP, Prusiner SB (1984) Molecular characteristics of the major scrapie prion protein. Biochemistry 23: 5898–5906Google Scholar
  25. Bolton DC, Meyer RK, Prusiner SB (1985) Scrapie PrP 27–30 is a sialoglycoprotein J Virol 53:596–606PubMedGoogle Scholar
  26. Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in culture cells. J Cell Biochem 14C: 72Google Scholar
  27. Braig H, Diringer H (1985) Scrapie: concept of a virus-induced amyloidosis of the brain. EMBO J 4: 2309–2312PubMedGoogle Scholar
  28. Brown P (1988) The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy. Neurology 38: 1135–1137PubMedGoogle Scholar
  29. Brown P, Coker-Vann M, Pomeroy K, Franko M, Asher DM, Gibbs CJ Jr, Gajdusek DC (1986) Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of maker protein in human brain tissue. N Engl J Med 314: 547–551PubMedGoogle Scholar
  30. Bruce ME, Dickinson AG (1987) Biological evidence that the scrapie agent has an independent genome. J Gen Virol 68: 79–89PubMedGoogle Scholar
  31. Bruce ME, Fraser H (1975) Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropathol Appl Neurol 1: 189–202Google Scholar
  32. Butler DA, Scott MRD, Bockman JM, Borchelt DR, Taraboulos A, Hsiao KK, Kingsbury DT, Prusiner SB (1988) Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 62: 1558–1564PubMedGoogle Scholar
  33. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond SJ, Westaway D, Prusiner SB (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46: 503–511PubMedGoogle Scholar
  34. Carlson GA, Goodman PA, Lovett M, Taylor BA, Marshall ST, Peterson-Torchia M, Westaway D, Prusiner SB (1988) Genetics and polymorphism of the mouse prion gene complex: the control of scrapie incubation time. Mol Cell Biol 8: 5528–5540PubMedGoogle Scholar
  35. Carlson GA, Westaway D, DeArmond SJ, Peterson-Torchia M, Prusiner SB (1989) Primary structure of prion protein may modify scrapie isolate properties. Proc Natl Acad Sci USA 86: 7475–7479PubMedGoogle Scholar
  36. Carp RI, Merz PA, Kascsak RJ, Merz GS, Wisniewski HM (1985) Nature of the scrapie agent: current status of facts and hypotheses. J Gen Virol 66: 1357–1368PubMedGoogle Scholar
  37. Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63: 175–181PubMedGoogle Scholar
  38. Chamberlin TC (1890) The method of multiple working hypotheses. Science [Old Series] 15: 92–97, reprinted in Science (1965) 148: 754–759Google Scholar
  39. Chandler RL (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet i: 1378–1379Google Scholar
  40. Chen S-H, Habib G, Yang C-Y, Gu Z-W, Lee BR, Weng S-A, Silberman SR, Cai SJ, Deslypere JP Rosseneu M, Gotto AM, Li W-H, Chan L (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238: 363–366PubMedGoogle Scholar
  41. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L, Keith JM, Garon C, Haase A (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315: 331–333PubMedGoogle Scholar
  42. Cho HJ (1980) Requirement of a protein component for scrapie infectivity. Intervirology 14: 213–216PubMedGoogle Scholar
  43. Collinge J, Harding AE, Owen F, Poulter M, Lofthouse R, Boughey AM, Shah T, Crow TJ (1989) Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet ii: 15–17Google Scholar
  44. Czub M, Braig HR, Blode H, Diringer H (1986) The major protein of SAF is absent from spleen and thus not an essential part of the scrapie agent. Arch Virol 91: 383–386PubMedGoogle Scholar
  45. Czub M, Braig HR, Diringer H (1988) Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis. J Gen Virol 69: 1753–1756PubMedGoogle Scholar
  46. DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41: 221–235PubMedGoogle Scholar
  47. Dickinson AG (1976) Scrapie in sheep and goats. In: Kimberlin RH (ed) Slow virus diseases of animals and man. North-Holland, Amsterdam, pp 209–241Google Scholar
  48. Dickinson AG, Outram GW (1979) The scrapie replication-site hypothesis and its implications for pathogenesis. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system vol 2. Academic, New York, pp 13–31Google Scholar
  49. Dickinson AG, Outram GW (1988) Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. In: Bock G, Marsh J (eds) Novel infectious agents and the central Nervous system. Wiley, Chichester, pp 63–83 (Ciba Found symp 135)Google Scholar
  50. Dickinson AG, Young GB, Stamp JT, Renwich CC (1965) An analysis of natural scrapie in Suffolk sheep. Heredity 20: 485–503PubMedGoogle Scholar
  51. Diener TO (1972) Is the scrapie agent a viroid? Nature 235: 218–219Google Scholar
  52. Diener TO (1987) PrP and the nature of the scrapie agent. Cell 49: 719–721PubMedGoogle Scholar
  53. Diener TO, McKinley MP, Prusiner SB (1982) Viroids and prions. Proc Natl Acad Sci USA 79: 5220–5224PubMedGoogle Scholar
  54. Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH (1983) Scrapie infectivity, fibrils and low molecular weight protein. Nature 306: 476–478PubMedGoogle Scholar
  55. Doh-ura K, Tateishi J, Sasaki H, Kitamoto T, Sakaki Y (1989) Pro → Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 163: 974–979Google Scholar
  56. Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures, linked to asparagines of the scrapie prion protein. Biochemistry 28: 8380–8388PubMedGoogle Scholar
  57. Feagin JE, Abraham JM, Stuart K (1988) Extensive editing of the cytochrome C oxidase III transcript in Trypanosoma brucei. Call 53: 413–422Google Scholar
  58. Ferguson MAJ, Williams AF (1988) Cell-surface anchoring of protein via glycosyl-phosphatidylinositol structures. Annu Rev Biochem 57: 285–320PubMedGoogle Scholar
  59. Field EJ (1966) Transmission experiments with multiple sclerosis: an interim report. Br Med J 2: 564–565PubMedGoogle Scholar
  60. Field EJ (1967) The significance of astroglial hypertrophy in scrapie, kuru, multiple sclerosis and old age together with a note on the possible nature of the scrapie agent. Dtsch Z Nervenheilkd 192: 265–274Google Scholar
  61. Field EJ, Farmer F, Caspary EA, Joyce G (1969) Susceptibility of scrapie agent to ionizing radiation. Nature 222: 90–91PubMedGoogle Scholar
  62. Fraser H, Bruce ME (1983) Experimental control of cerebral amyloid in scrapie in mice. In: Behan PO et al. (eds) Immunology of nervous system infections Elsevier, Amsterdam, pp 281 – 290 (progress in brain research, vol 59)Google Scholar
  63. Fraser H, McConnell I, Wells GAH, Dawson M (1988) Transmission of bovine spongiform encephalopathy to mice. Vet Rec 123: 472PubMedGoogle Scholar
  64. Gabizon R, Prusiner SB (1990) Prion liposomes. Biochem J 266: 1–14PubMedGoogle Scholar
  65. Gabizon R, McKinley MP, Groth DF, Kenaga L, Prusiner SB (1988a) Properties of scrapie prion liposomes. J Biol Chem 263: 4950–4955PubMedGoogle Scholar
  66. Gabizon R, McKinley MP, Groth DF, Prusiner SB (1988b) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci USA 85: 6617–6621PubMedGoogle Scholar
  67. Gabizon R, McKinley MP, Prusiner SB (1987) Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl AGad USA 84: 4017–4021Google Scholar
  68. Gajdusek DC (1977) Unconventional viruses and the origin and disappearance of kuru. Science 197: 943–960PubMedGoogle Scholar
  69. Gajdusek DC (1988) Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations. J Neuroimmunol 20: 95–110PubMedGoogle Scholar
  70. Gajdusek DC (1986) Chronic dementia caused by small unconventional viruses apparently containing no nucleic acid. In: Scheibel AB, Wechsler AF, Brazier MAB (eds) The biological substrates of Alzheimer’s disease. Academic, Orlando, pp 33–54 (UCLA forum in medical sciences, no 27)Google Scholar
  71. Gajdusek DC, Gibbs CJ Jr, Alpers M (1986) Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209: 794–796Google Scholar
  72. Ghetti B, Farlow M, Conneally M, Azzarelli B, Masters C, Giaccone G, Tagliavini F, Bugiani O (1988) Amyloid plaques and neurofibrillary tangles of Gerstmann-Sträussler-Scheinker disease. Neurology 38 (Suppl 1): 266Google Scholar
  73. Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlow MR, Conneally PM, Dlouhy SR, Azzarelli B, Bugiani O (1989) Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39:1453–1461PubMedGoogle Scholar
  74. Gibbons RA, Hunter GD (1967) Nature of the scrapie agent. Nature 215: 1041–1043PubMedGoogle Scholar
  75. Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161:388–389PubMedGoogle Scholar
  76. Gibbs CJ Jr, Gajdusek DC, Latarjet R (1978) Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease and scrapie. Proc Natl Acad Sci USA 75: 6268–6270PubMedGoogle Scholar
  77. Gibbs CJ JR, Joy A, Heffner R, Franko M, Miyazaki M, Asher DM, Parisi JE, Brown PW, Gajdusek DC (1985) Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313: 734–738PubMedGoogle Scholar
  78. Goldgaber D, Goldfarb LG, Brown P, Asher DM, Brown WT, Lin S, Teener JW, Feinstone SM, Rubenstein R, Kascsak RJ, Boellaard JW, Gajdusek DC (1989) Mutation in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker syndrome. Exp Neurol 106: 204–206PubMedGoogle Scholar
  79. Goldman W, Hunter N, Multhaup G, Salbalm JM, Foster JD, Beyreuther KT, Hope J (1988) The PrP gene in natural scrapie. Alzheimers Dis Assoc Disorders [Abstr suppl]: 330Google Scholar
  80. Gordon WS (1946) Advances in veterinary research. Vet Res 58: 516–520Google Scholar
  81. Gordon WS (1966) Review of work on scrapie at Compton, England, 1952–1964. In: Report of scrapie seminar, ARS 91-53. US Department of Agriculture, Washington DC, pp 19–36Google Scholar
  82. Goujard J, Entat M, Maillard F, Mugnier E, Rappaport R, Job JC (1988) Human pituitary growth hormone (hgH) and Creutzfeldt-Jakob disease: results of an epidemiological survey in France, 1986. Int J Epidemiol 17: 423–427PubMedGoogle Scholar
  83. Griffith JS (1967) Self-replication and scrapie. Nature 215: 1043–1044PubMedGoogle Scholar
  84. Hadlow WJ, Karstad L (1968) Transmissible encephalopathy of mink in Ontario. Can Vet J 9:193–196PubMedGoogle Scholar
  85. Hadlow WJ, Race RE (1986) Cerebrocortical degeneration in goats inoculatd with mink-passaged scrapie virus. Vet Pathol 23: 543–549PubMedGoogle Scholar
  86. Hadlow WJ, Race RE, Kennedy RC (1987) Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J Virol 61: 3235–3240PubMedGoogle Scholar
  87. Hansen MF, Cavenee WK (1987) Genetics of cancer predisposition. Cancer Res 47: 5518–5527PubMedGoogle Scholar
  88. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D Tarantino A, Borchelt DR, Teplow D, Hood L, Burlingame A, Lycke E, Kobata A, Prusiner SB (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274: 1–13PubMedGoogle Scholar
  89. Hardy J (1989) “Slow virus” dementias: prion gene holds the key. Trends Neurosci 12: 168–169PubMedGoogle Scholar
  90. Harmon JT, Nielsen TB, Kempner ES (1985) Molecular weight determinations from radiation inactivation. Methods Enzymol 117: 65–94PubMedGoogle Scholar
  91. Hartsough GR, Burger D (1965) Encephalopathy of mink. I. Epizootiologic and clinical observations. J Infect Dis 115:387–392PubMedGoogle Scholar
  92. Hay B, Barry RA, Lieberburg I, Prusiner SB, Lingappa VR (1987) Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein. Mol Cell Biol 7:914–920PubMedGoogle Scholar
  93. Hope J, Kimberlin RH (1987) The molecular biology of scrapie: The last two years. Trends Neurosci 10: 149–151Google Scholar
  94. Hope J, Morton LJD, Farquhar CF, Multhaup G, Beyreuther K, Kimberlin RH (1986) The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J 5: 2591–2597PubMedGoogle Scholar
  95. Hope J, Multhaup G, Reekie LJD, Kimberlin RH, Beyreuther K (1988a) Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur J Biochem 172:271–277PubMedGoogle Scholar
  96. Hope J, Reekie LJD, Hunter N, Multhaup G, Beyreuther K, White H, Scott AC, Stack MJ, Dawson M, Wells GAH (1988b) Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 336: 390–392PubMedGoogle Scholar
  97. Hourrigan J, Klingsporn A, Clark WW, de Camp M (1979) Epidemiology of scrapie in the United States. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system vol 1. Academic, New York, pp 331–356Google Scholar
  98. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Geratmann-Sträussler Syndrome. Nature 338: 342–345PubMedGoogle Scholar
  99. Hunter GD, Millson GC (1967) Attempts to release the scrapie agent from tissue debris. J Comp Pathol 77:301–327PubMedGoogle Scholar
  100. Hunter GD, Kimberlin RH, Gibbons RA (1968) Scrapie: a modified membrane hypothesis. J Theor Biol 20: 355–357PubMedGoogle Scholar
  101. Hunter N, Hope J, McConnell I, Dickinson AG (1987) Linkage of the scrapie-associated fibril protein (PrP) gene and Sine using congenic mice and restriction fragment length polymorphism analysis. J Gen Virol 68: 2711–2716PubMedGoogle Scholar
  102. Ito M, Shinagawa M, Doi S, Sasaki S, Isomura H, Takahashi K, Goto H, Sato G (1988) Effects of the antiserum against a fraction enriched in scrapie-associated fibrils on the scrapie incubation period in mice. Microbiol Immunol 32: 749–753PubMedGoogle Scholar
  103. Kempner ES, Miller JH, McCreery MJ (1986a) Radiation target analysis of glycoproteins. Anal Biochem 156: 140–146PubMedGoogle Scholar
  104. Kempner ES, Wood R, Salovey R (1986b) The temperature dependence of radiation sensitivity of large molecules. J Polym Sci Polym Phys Ed 24: 2337–2343Google Scholar
  105. Kimberlin RH, Cole S, Walker CA (1987) Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 68: 1875–1881PubMedGoogle Scholar
  106. Kimberlin RH, Walker CA, Fraser H (1989) The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice, J Gen Virol 70: 2017–2025PubMedGoogle Scholar
  107. Kingsbury DT, Smeltzer D, Bockman J (1984) Purification and properties of the K. Fu. isolate of the agent of Creutzfeldt-Jakob disease. 6 international congress on virology 1 – 7 Sept 1984, Sendai, p 70 (abstr no W 47–6)Google Scholar
  108. Kitamoto T, Tateishi J, Tashima I, Takeshita J, Barry RA, DeArmond SJ, Prusiner SB (1986) Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol 20:204–208PubMedGoogle Scholar
  109. Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of kuru. Lab Invest 8: 799–847PubMedGoogle Scholar
  110. Kovanen J, Haltia M (1988) Descriptive epidemiology of Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand 77: 474–480PubMedGoogle Scholar
  111. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986a) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122: 1–5PubMedGoogle Scholar
  112. Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, DeArmond SJ (1986b) Molecular cloning of a human prion protein cDNA. DNA 5: 315–324PubMedGoogle Scholar
  113. Latarjet R (1979) Inactivation of the agents of scrapie, Creutzfeldt-Jakob disease, and kuru by radiations. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic, New York, pp 387–408Google Scholar
  114. Lewin P (1972) Scrapie: an infective peptide? Lancet i: 748Google Scholar
  115. Lewin P (1981) Infectious peptides in slow virus infections: a hypothesis. Can med Assoc J 124: 1436–1437PubMedGoogle Scholar
  116. Liao Y-C, Tokes Z, Lim E, Lackey A, Woo CH, Button JD, Clawson GA (1987) Cloning of rat “prion-related protein” cDNA. Invest 57: 370–374Google Scholar
  117. Locht C, Chesebro B, Race R, Keith JM (1986) Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci USA 83: 6372–6376PubMedGoogle Scholar
  118. Lowenstein DH, Butler DA, Westaway D, McKinley MP, DeArmond SJ, Prusiner SB (1990) Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins. Mol Cell Biol 10: 1153–1163PubMedGoogle Scholar
  119. Luria SE, Delbruck M (1943) Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491–511PubMedGoogle Scholar
  120. Malone TG, Marsh RF, Hanson RP, Semancik JS (1979) Evidence for the low molecular weight nature of the scrapie agent. Nature 278: 575–576PubMedGoogle Scholar
  121. Manuelidis L, Sklaviadis T, Manuelidis EE (1987) Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J 6: 341–347PubMedGoogle Scholar
  122. Marsh RF, Kimberlin RH (1975) Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogenesis. J Infect Dis 131: 104–110PubMedGoogle Scholar
  123. Marsh RF, Malone TG, Semancik JS, Lancaster WD, Hanson RP (1978) Evidence for an essential DNA component in the scrapie agent. Nature 275: 146–147PubMedGoogle Scholar
  124. Masters CL, Gajdusek DC, Gibbs C Jr (1981a) Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. Brain 104: 559–588PubMedGoogle Scholar
  125. Masters CL, Gajdusek DC, Gibbs C Jr (1981 b) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer’s disease/Brain 104: 535–558PubMedGoogle Scholar
  126. McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57–62PubMedGoogle Scholar
  127. McKinley MP, Braunfeld MB, Bellinger CG, Prusiner SB (1986) Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J Infect Dis 154: 110–120PubMedGoogle Scholar
  128. McKinley MP, Butler DA, Prusiner SB (1987) Prion protein mRNA in hamsters and mice. J Cell Biol 105: 317aGoogle Scholar
  129. Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB (1986) Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83: 2310–2314PubMedGoogle Scholar
  130. M’Gowan JP (1914) Investigation into the disease of sheep called “scrapie”. William Blackwood, EdinburghGoogle Scholar
  131. Millson GC, Hunter GD, Kimberlin RH (1976) The physico-chemical nature of the scrapie agent. In: Kimberlin RH (ed) slow virus diseases of animals and man. American Elsevier, New York, pp 243–266Google Scholar
  132. Nochlin D, Sumi SM, Bird TD, Snow AD, Leventhal CM, Beyreuther K, Masters CL (1989) Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 39: 910–918PubMedGoogle Scholar
  133. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735–746PubMedGoogle Scholar
  134. Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, Risby D, Baker HF, Ridley RM, Hsiao K, Prusiner SB (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet i 51–52Google Scholar
  135. Parry HB (1962) Scrapie: a transmissible and hereditary disease of sheep. Heredity 17: 75–105PubMedGoogle Scholar
  136. Parry HB (1983) Oppenheimer DR (ed) Scrapie disease in sheep. Academic, New YorkGoogle Scholar
  137. Pattison IH (1965) Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. In: Gajdusek DC, Gibbs CJ Jr, Alpers MP (eds) Slow, latent and temperate virus infections. U S Government Printing Office, Washington D C, pp 249–257 (National Institute of Neurological and Communicable Diseases and Blindness monograph no 2)Google Scholar
  138. Pattison IH (1988) Fifty years with scrapie: a personal reminiscence. Vet Rec 123: 661–666PubMedGoogle Scholar
  139. Pattison IH, Jones KM (1967) The possible nature of the transmissible agent of scrapie. Vet Rec 80: 1–8Google Scholar
  140. Pattison IH, Millson GC (1961) Experimental transmission of scrapie to goats and sheep by the oral route. J Comp Pathol 71: 171–176Google Scholar
  141. Pattison IH, Hoare MN, Jebbett JN, Watson WA (1972) Spread of scrapie to sheep and goats by oral dosing with foetal membranes from scrapie-affected sheep. Vet Rec 90: 465–468PubMedGoogle Scholar
  142. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J (1987) A novel form of tissue-specific RNA processing produces apolipoprotein B-48 in intestine. Cell 50: 831–840PubMedGoogle Scholar
  143. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144PubMedGoogle Scholar
  144. Prusiner SB (1987) Prions and neurodegenerative diseases. N Engl J Med 317: 1571–1581PubMedGoogle Scholar
  145. Prusiner SB (1989) Scrapie prions. Annu Rev Microbiol 43: 345–374PubMedGoogle Scholar
  146. Prusiner SB, Hadlow WJ, Garfin DE, Cochran SP, Baringer JR, Race RE, Eklund CM (1978) Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry 17: 4993–4997PubMedGoogle Scholar
  147. Prusiner SB, Garfin DE, Baringer JR, Cochran SP, Hadlow WJ, Race RE, Eklund CM (1979) On the partial purification and apparent hydrophobicity of the scrapie agent. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic, New York, pp 425–464Google Scholar
  148. Prusiner SB, Groth DF, Bildstein C, Masiarz FR, McKinley MP, Cochran SP (1980a) Electrophoretic properties of the scrapie agent in agarose gels. Proc Natl Acad Sci USA 77: 2984–2988PubMedGoogle Scholar
  149. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM (1980b) Molecular properties, partial purifications, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19: 4883–4891PubMedGoogle Scholar
  150. Prusiner SB, Groth DF, McKinley MP, Cochran SP, Bowman KA, Kasper KC (1981 a) Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc Natl Acad Sci USA 78: 4606–4610PubMedGoogle Scholar
  151. Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP, Masiarz FR (1981 b) Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 78: 6675–6679PubMedGoogle Scholar
  152. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP (1982a) Further purification and characterization of scrapie prions. Biochemistry 21: 6942–6950PubMedGoogle Scholar
  153. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982b) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11: 353–358PubMedGoogle Scholar
  154. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349–358PubMedGoogle Scholar
  155. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE (1984) Purification and structural studies of a major scrapie prion protein. Cell 38: 127–134PubMedGoogle Scholar
  156. Prusiner SB, Cochran SP, Alpers MP (1985) Transmission of scrapie in hamsters. J Infect Dis 152: 971–978PubMedGoogle Scholar
  157. Race RE, Fadness LH, Chesebro B (1987) Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol 68: 1391–1399PubMedGoogle Scholar
  158. Ridley RM, Baker HF, Crow TJ (1986) Transmissible and non-transmissible neurodegenerative disease: similarities in age of onset and genetics in relation to aetiology. Psychol Med 16:199–207PubMedGoogle Scholar
  159. Robakis NK, Sawh PR, Wolfe GC, Rubenstein R, Carp RI, Innis MA (1986) Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc Natl Acad Sci USA 83: 6377–6381PubMedGoogle Scholar
  160. Roberts GW, Lofthouse R, Brown R, Crow TJ, Barry RA, Prusiner SB (1986) Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med 315: 1231–1233Google Scholar
  161. Rohwer RG (1984a) Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature 308: 658–662PubMedGoogle Scholar
  162. Rohwer RG (1984b) Virus-like sensitivity of the scrapie agent to heat inactivation. Science 223: 600–602PubMedGoogle Scholar
  163. Rohwer RG (1986) Estimation of scrapie nucleic acid molecular weight from standard curves for virus sensitivity to ionizing radiation. Nature. 320: 381PubMedGoogle Scholar
  164. Rohwer RG, Gajdusek DC (1980) Scrapie-virus or viroid, the case for a virus. In: Boese A (ed) Search for the cause of multiple sclerosis and other chronic diseases of the central nervous system. Verlag Chemie, Weinheim, pp 333–355Google Scholar
  165. Rubenstein R, Kascsak RJ, Merz PA, Papini MC, Carp RI, Robakis NK, Wisniewski HM (1986) Detection of scrapie associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissued preparations. J Gen Virol 67: 671–681PubMedGoogle Scholar
  166. Scott M, Foster D, Mirenda C, Serban D, Coutal F, Walchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D, Prusiner SB (1989) Transgenic mice expressing hamster prion protein produce species-specitic scrapie infectivity and amyloid plaques. Cell 59: 847–857PubMedGoogle Scholar
  167. Serban D, Taraboulos A, DeArmond SJ, Prusiner SB (1990) Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40: 110–117PubMedGoogle Scholar
  168. Shaw JM, Feagin JE, Stuart K, Simpson L (1988) Editing of kinetoplastid mitochondrial mRNAs by uridine addition and deletion generates conserved amino acid sequences and AUG initiation codons. Cell 53: 401–411PubMedGoogle Scholar
  169. Shinagawa M, Munekata E, Doi S, Takahashi K, Goto H, Sato G (1986) Immunoreactivity of a synthetic pentadecapeptide corresponding to the N-terminal region of the scrapie prion protein. J Gen Virol 67: 1745–1750PubMedGoogle Scholar
  170. Sparkes RS, Simon M, Cohn VH, Fournier REK, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T, DeArmond SJ, Westaway D, Prusiner SB (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 83:7358–7362PubMedGoogle Scholar
  171. Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phospha-tidylinositol glycolipid. Cell 51: 229–240PubMedGoogle Scholar
  172. Stahl N, Borchelt DR, Prusiner SB (1990) Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29: 5405–5412PubMedGoogle Scholar
  173. Taraboulos A, Serban D, Prusiner SB (1990) Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol 110: 2117–2132PubMedGoogle Scholar
  174. Turk E, Teplow DB, Hood LE, Prusiner SB (1988) Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem 176: 21–30PubMedGoogle Scholar
  175. Weissmann C (1989) Prions: sheep disease in human clothing. Nature 338: 298–299PubMedGoogle Scholar
  176. Wells GAH, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R (1987) A novel progressive spongiform encephalopathy in cattle. Vet Rec 121: 419–420PubMedGoogle Scholar
  177. Westaway D, Prusiner SB (1986) Conservation of the cellular gene encoding the scrapie prion protein. Nucleic Acids Res 14: 2035–2044PubMedGoogle Scholar
  178. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, Prusiner SB (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51: 651–662PubMedGoogle Scholar
  179. Westaway D, Carlson GA, Prusiner SB (1989) Unraveling prion diseases through molecular genetics. Trends Neurosci 12: 221–227PubMedGoogle Scholar
  180. Wilesmith JW (1988) Bovine spongiform encephalopathy. Vet Rec 122: 614PubMedGoogle Scholar
  181. Wilesmith JW, Wells GAH, Cranwell MP, Ryan JBM (1988) Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 123: 638–644PubMedGoogle Scholar
  182. Williams ES, Young S (1980) Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 16: 89–98PubMedGoogle Scholar
  183. Wisniewski HM, Bruce ME, Fraser H (1975) Infectious etiology of neuritic (senile) plaques in mice. Science 190: 1108–1110PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1991

Authors and Affiliations

  • S. B. Prusiner
    • 1
  1. 1.Departments of Neurology and of Biochemistry and BiophysicsUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations